C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2002
11/27/2002	EP0783316B1 Antifungal and antibiotic synthetic peptides
11/27/2002	EP0776331B1 Higher order structure and binding of peptide nucleic acids
11/27/2002	EP0671928B1 Synthesis of n-substituted oligomers
11/27/2002	CN1381501A Tumor necrosis factor inhibiting peptide and its application
11/26/2002	CA2107672C Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
11/26/2002	CA2067901C Novel polypeptides with affinity to lipopolysaccharides and their uses
11/26/2002	CA2066913C Novel binding peptides
11/21/2002	WO2003099841A2 Peptides and the use thereof in darkening the skin
11/21/2002	WO2003099248A1 Composition containing a peptide and a pigment and the use thereof in darkening the skin
11/21/2002	WO2002092781A2 Peptide compounds for counteracting reactive oxygen species and free radicals
11/21/2002	WO2002092630A1 High density lipoprotein-reactive peptides
11/21/2002	WO2002092623A1 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
11/21/2002	WO2002092620A2 Peptides and related molecules that bind to tall-1
11/21/2002	WO2002092118A1 Global analysis of protein activities using proteome chips
11/21/2002	WO2002092115A2 Method of preventing cell death using segments of neural thread proteins
11/21/2002	WO2002092032A1 Use of 3-position cyclosporin derivatives for hair growth
11/21/2002	WO2002074981A3 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
11/21/2002	WO2002018341A9 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
11/21/2002	US20020173642 Human gastric cancer antigen gene and gastric cancer antigen protein
11/21/2002	US20020173475 Methods to inhibit viral replication
11/21/2002	US20020173474 Methods & materials involving dimerization-mediated regulation of biological events
11/21/2002	US20020173467 Peptide in biopolymer; oil in water emulsion
11/21/2002	US20020173459 Isolated peptide; antibodies; genetic engineering
11/21/2002	US20020173456 Complex of macromolecules and peptide; supplying cells
11/21/2002	US20020173452 Cytostatic-glycoconjugates having specifically cleavable linking units
11/21/2002	US20020173049 Controlling protein levels in eucaryotic organisms
11/21/2002	US20020173007 Human chemokine polypeptides
11/21/2002	US20020172962 Generation of nucleotide sequence ligands; obtain nucleotide sequences mixture, separate nucleotide sequences, amplify nucleotide sequences, incubate with modulator, detect adjustment in binding activity
11/21/2002	CA2447431A1 Inhibitors of receptor activator of nf-kb and uses thereof
11/21/2002	CA2447292A1 Peptide compounds for counteracting reactive oxygen species and free radicals
11/21/2002	CA2446945A1 Method of preventing cell death using segments of neural thread proteins
11/21/2002	CA2446867A1 Global analysis of protein activities using proteome chips
11/21/2002	CA2446720A1 High density lipoprotein-reactive peptides
11/20/2002	EP1258492A1 N-substituted oligomers and methods for their synthesis, e.g. polyglycine bearing nucleic acid bases
11/20/2002	EP1257568A1 Novel echinocandin derivatives, preparation method and use thereof as fungicides
11/20/2002	EP1257567A2 Cationic, amphipathic beta-sheet peptides and uses thereof
11/20/2002	EP1257284A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
11/20/2002	CN1380341A Single-stranded cyctic trispecific antibody
11/20/2002	CN1094342C Cosmetic preparation with peptide addition
11/19/2002	US6482943 Quinones as disease therapies
11/19/2002	US6482929 Antibodies to ARF-p19
11/19/2002	US6482928 Fab′-epitope complex from HIV-1 cross-neutralizing monoclonal antibody 2F5
11/19/2002	US6482800 Methods to stimulate angiogenesis
11/19/2002	US6482797 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ACE)
11/19/2002	US6482591 Libraries of unimolecular, double-stranded oligonucleotides on solid support, useful in screening procedures associated with drug discovery and diagnosis
11/19/2002	US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites
11/19/2002	CA2272990C Heptapeptide oxytocin analogues
11/19/2002	CA2261579C Isolated peptides derived from mage-2
11/14/2002	WO2002090981A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof
11/14/2002	WO2002090503A2 Anti-microbial peptides and compositions
11/14/2002	WO2002089789A1 Trimethyl lock based tetrapartate prodrugs
11/14/2002	WO2001031036A9 Modified viral surface proteins which bind to cells of tumor vasculature
11/14/2002	US20020169132 Polypeptides
11/14/2002	US20020169125 Fusion protein such as of polyglutamic acid and interferon-alpha; improves bioactivity and water-solubility properties of a drug to which it is conjugated
11/14/2002	US20020169114 Formulation of boronic acid compounds
11/14/2002	US20020168761 Cell adhesion modulator for use in the treatment of nervous system disorders
11/14/2002	US20020168684 Generating preferential immunoglobulins; obtain peptide library, immunize cells, isolate anitgen, purify immunoglobulin
11/14/2002	US20020168628 Variant of LAV viruses
11/14/2002	US20020168392 Antimicrobial proteins
11/14/2002	US20020168379 Veterinary medicine; swine respiratory system disorders
11/14/2002	CA2446322A1 Anti-microbial peptides and compositions
11/14/2002	CA2445065A1 Trimethyl lock based tetrapartate prodrugs
11/13/2002	EP1256352A2 Immunomodulatory peptides
11/13/2002	EP1255845A2 Modified cytokines for use in cancer therapy
11/13/2002	EP1255770A1 Melanin-concentrating hormone analogs
11/13/2002	EP1255555A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
11/13/2002	EP1007078A4 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties
11/13/2002	EP0449958B2 Meningococcal class 1 outer-membrane protein vaccine
11/13/2002	CN1379858A Specific autoimmunity reaction against isomerization/optical reverse antigenic determinant; application in autoimmunity disease diagnosis
11/13/2002	CN1379786A Modified peptides and peptidomimetics for use in immunotherapy
11/13/2002	CN1379041A Cytotoxin T lymphocyte
11/12/2002	US6479460 Pseudopeptidic osteogenic growth polypeptide
11/12/2002	US6479457 Polypeptide comprising at least one effective ionogenic amine ionically bound to polymer; drug delivery systems for the controlled release of pharmaceutical polypeptides
11/12/2002	US6479265 Catalytic antibodies which hydrolyze primary amides and methods for eliciting and use of such antibodies
11/12/2002	US6479055 Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
11/12/2002	CA2204535C Molecules that home to a selected organ or tissue in vivo and methods of identifying same
11/12/2002	CA2138647C Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
11/07/2002	WO2002088358A2 Human fibroblast growth factor-related compositions
11/07/2002	WO2002088318A2 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002	WO2002087631A1 Gastrin-receptor-avid peptide conjugates
11/07/2002	WO2002087504A2 Methods for inhibiting tumor cell proliferation
11/07/2002	WO2001092300A3 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level
11/07/2002	WO2001046220A3 Bioactive oligopeptides
11/07/2002	US20020165355 Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
11/07/2002	US20020165164 New effectors of dipeptidyl peptidase IV for topical use
11/07/2002	US20020165159 Administering a luteinizing hormone releasing hormone antagonist or agonist peptide to selectively change the amount of follicle- stimulating hormone (FSH) in blood to control fertility
11/07/2002	US20020165150 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors
11/07/2002	US20020165141 Methods for promoting dendritic cell proliferation or differentiation
11/07/2002	US20020165132 Lanthionine bridged peptides
11/07/2002	US20020165126 Method for inactivating gonadotrophs
11/07/2002	US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002	US20020164718 Metal ion affinity tags and methods for usig the same
11/07/2002	US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002	US20020164679 Polypeptides for use in the treatment of atherosclerosis and cardiovascular disorders
11/07/2002	US20020164620 Method for identifying compounds modulating sister chromatid separation
11/07/2002	US20020164329 Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides
11/07/2002	US20020162789 Subjecting cyclosporin complex to multistep silica gel column chromatography in which the mobile phase is a solvent comprising toluene as the main component
11/07/2002	CA2445947A1 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002	CA2443719A1 Human fibroblast growth factor-related compositions
11/06/2002	EP1254163A2 Targeting peptides

1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 423